平安好医生(01833.HK)止跌弹逾半成发布战略级新产品
平安好医生(01833.HK)发布战略级新产品,推出「私人医生」新服务及建立医患深厚关系。该股扭七连跌,由近五个月低位回升,最高见33.9元,半日收33.85元,反弹5.3%,半日成交额1,559万元。
平安好医生公布,推出战略新产品「平安好医生私人医生」,为超过2亿新中产人群打造的全方位、高品质的医疗健康服务,提供包括健康管理、即时问诊谘询、名医二诊和线下门诊就医安排等一站式医疗健康服务。公司指,通过创新私人医生服务模式,能让医生与用户全方位互动,医生可以长期追踪用户健康状况,双方像是熟人般紧密联系并建立深厚信任关系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.